📰 Resented News
Page 6 - Resented News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Resented. Real-time updates on events, politics, business and more.
June 6, 2023
Newell Brands Inc. presented today at the 2023 dbAccess Global Consumer Conference in Paris. Chris Peterson, President and Chief Executive Officer, and Mark Erceg, Chief Financial Officer, provided... | June 6, 2023
June 5, 2023
On June 5th, Lexus premiered the all-new LBX. Presented to media at an event in Milan, Italy, by Chief Branding Officer Simon Humphries and Lexus President Takashi Watanabe, the new... | June 5, 2023
June 5, 2023
SOUTH SAN FRANCISCO - Allogene Therapeutics, Inc. , a clinical-stage biotechnology company pioneering the development of allogeneic CAR T products for cancer, today presented long-term follow up... | June 5, 2023
June 5, 2023
Preclinical data on UCART20x22, Cellectis’ first allogeneic dual CAR T-cell product candidate to treat B-NHL, presented at an oral session Encouraging data presented on gene editing process... | June 5, 2023
June 4, 2023
CHICAGO, IL / ACCESSWIRE / June 4, 2023 / UCM Technologies has utilized a breakthrough combination of biomarkers (CA-62, CEA and CYFRA 21-1) to detect lung cancer at its earliest stages (stages I-II) with
June 4, 2023
Cantargia today presented interim efficacy data for 39 non-small cell lung cancer patients treated with nadunolimab and platinum-based chemotherapy as a poster at the ASCO Annual Meeting 2023 , and... | June 4, 2023
June 2, 2023
LONDON, June 2, 2023 /PRNewswire/ -- The World Climate Industry EXPO in Busan became a great opportunity for BE OPEN to present its SDG-focused programme and in particular the ongoing student
June 1, 2023
Vancouver, British Columbia--(Newsfile Corp. - June 1, 2023) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a leader in the pharmaceutical research, development, manufacturing
June 1, 2023
UPPSALA, SE / ACCESSWIRE / June 1, 2023 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in cancer diagnostics, today announces that a poster with DiviTum® TKa results from